Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02341664 · ClinicalTrials.gov registry record
Patient and Provider Assessment of Lipid Management Registry
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 7,658
- Enrollment target
NCT02341664 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 7,658 participants.
The verdict
NCT02341664 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 7,658 participants
- Enrollment target
Study Summary
The purpose of the Patient and Provider Assessment of Lipid Management Registry (PALM) is to gain a better understanding of physicians' cholesterol medication prescribing practices, patient and physician attitudes and beliefs related to cholesterol management, and current utilization of cholesterol-lowering therapies given the new ACC/AHA guideline recommendations. The PALM Registry hopes to allow for the design of ways to improve cholesterol management and decrease the burden of cardiovascular disease (CVD) in the US.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,658 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02341664
The ClinicalTrials.gov registry entry for NCT02341664 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,658 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02341664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02341664 about?
NCT02341664 is a clinical study titled "Patient and Provider Assessment of Lipid Management Registry". The purpose of the Patient and Provider Assessment of Lipid Management Registry (PALM) is to gain a better understanding of physicians' cholesterol medication prescribing practices, patient and physician attitudes and beliefs related to cholesterol management, and current utilization of cholesterol-...
What is the current status of trial NCT02341664?
This trial is currently completed. The enrollment target is 7,658 participants. The study started on 2015-05. Estimated completion is 2016-02.
Who is sponsoring clinical trial NCT02341664?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.